Although previous report demonstrated that TPCK inhibits TRAIL-mediated caspase activity and PDK/AKT signaling in human prostatic carcinoma cell lines [31], our data indicated that induced AKT signaling by TNFα was not affected by TPCK in myeloma cells (Figure 5). Here, AKT1 is linked to prostate carcinoma.